Filter
481
Text search:
Emergency
Use
Authorization
Featured
Recommendations
51
New Publications
112
Language
Document type
No document type
206
Guidelines
107
Studies & Reports
79
Manuals
30
Strategic & Response Plan
22
Fact sheets
22
Training Material
10
Situation Updates
3
Resource Platforms
2
Countries / Regions
India
18
Kenya
18
Myanmar / Burma
15
Global
14
Latin America and the Carribbean
11
Nigeria
10
Africa
9
Sierra Leone
8
Liberia
8
Ghana
8
Western and Central Europe
8
Syria
7
Rwanda
7
Bangladesh
7
Haiti
6
Nepal
6
Malawi
6
East and Southern Africa
6
West and Central Africa
6
Congo, Democratic Republic of
5
South Sudan
5
South Africa
5
Senegal
4
Ethiopia
4
Cameroon
4
Uganda
4
Zimbabwe
4
Germany
4
Tanzania
4
Brazil
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Guinea
3
Philippines
3
Cambodia
3
Eswatini/ Swaziland
3
Ecuador
3
Yemen
3
Venezuela
3
Russia
3
Mali
2
Pakistan
2
Afghanistan
2
Thailand
2
Namibia
2
Colombia
2
Lesotho
2
South–East Asia Region
2
Eastern Europe
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Iraq
1
Zambia
1
Chad
1
Gambia
1
Indonesia
1
Peru
1
North Macedonia
1
Serbia
1
Ukraine
1
Bolivia
1
Libya
1
Chile
1
Paraguay
1
Asia
1
Palestine
1
Albania
1
Armenia
1
Laos
1
Tajikistan
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Vietnam
1
Maldives
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
172
Key Resources
37
Clinical Guidelines
34
Women & Child Health
24
Public Health
17
Pharmacy & Technologies
12
Capacity Building
3
Toolboxes
COVID-19
125
Pharmacy
23
Rapid Response
22
Ebola & Marburg
21
HIV
19
Conflict
14
AMR
13
2.0 Rapid Response
11
TB
10
Planetary Health
10
Natural Hazards
9
Mental Health
9
Refugee
8
Specific Hazards
7
Global Health Education
6
Caregiver
6
Malaria
6
Zika
5
Health Financing Toolbox
5
Cholera
3
NTDs
3
Disability
2
NCDs
2
Polio
1
Social Ethics
1
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency
...
African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine
10 March 2021
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency
...
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and proced
...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonization (AMRH) Initiative, and the World Health Organisat
...
The purpose of this document is to stop to irrational use/ over prescription of this reserve/
experimental/ emergency use authoris
...
This Joint Emergency Management Plan of the International Organizations (Joint Plan) describes the
interagency framework of preparedness for and response to an actual, potential or perceived nuclear or
radiological
...
A Guide for UNICEF Staff
The Interagency Emergency Health Kit 2017
recommended
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
Myanmar is prone to various natural hazards that include earthquakes, floods, cyclones, droughts, fires, tsunamis, some of whichhave the potential to impact large numbers of people. In the event that large numbers of people are affected (such as was the case in 2008 following cyclone Nargis), the go
...
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence s
...
